On February 18, 2025, US President Donald Trump signed an executive order directing his administration to develop policy recommendations within 90 days to increase access to in vitro fertilization (IVF) services and to reduce the cost of IVF treatments for patients.
While the executive order has no immediate impact, it represents the Trump administration’s first step in addressing campaign promises to expand coverage for IVF services and limit the out-of-pocket and health insurance costs of IVF treatments. Given bipartisan support for these efforts in US Congress, there is potential for some action at the federal level even though several states already mandate coverage of certain IVF services by health insurance plans. Particular interest will be on how the Trump administration plans to make IVF services more affordable and ensure access to IVF treatment, with the executive order highlighting the Trump administration’s goal of easing “unnecessary statutory or regulatory burdens.”
Interested parties should continue to monitor developments in this space by the Trump administration and in Congress, with the McDermott health & life sciences team ready to help with navigating federal statutory or regulatory changes impacting the fertility industry.
[View source.]
